Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.

C. Koenecke, N. Czeloth, A. Bubke, S. Schmitz, Adrien Kissenpfennig, B. Malissen, J. Huehn, A. Ganser, R. Förster, I. Prinz

Research output: Contribution to journalArticle

96 Citations (Scopus)
24 Downloads (Pure)
Original languageEnglish
Pages (from-to)3091-3096
Number of pages6
JournalEuropean Journal of Immunology
Volume39(11)
Issue number11
DOIs
Publication statusPublished - Nov 2009

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Koenecke, C., Czeloth, N., Bubke, A., Schmitz, S., Kissenpfennig, A., Malissen, B., Huehn, J., Ganser, A., Förster, R., & Prinz, I. (2009). Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. European Journal of Immunology, 39(11)(11), 3091-3096. https://doi.org/10.1002/eji.200939432